ECEVİT, Ç. Et Al. 2016. Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients. The 48th Congress of the International Society of Paedriatric Oncology (SIOP) , (Dublin, Ireland), 237.

ECEVİT, Ç., AKTAŞ, S., YILDIRIM, H., DEMİRAĞ, B., ERBAY, A., KARACA, İ., ... ÇELİK, A.(2016). Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients . The 48th Congress of the International Society of Paedriatric Oncology (SIOP) (pp.237). Dublin, Ireland

ECEVİT, ÇİĞDEM Et Al. "Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients," The 48th Congress of the International Society of Paedriatric Oncology (SIOP), Dublin, Ireland, 2016

ECEVİT, ÇİĞDEM Et Al. "Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients." The 48th Congress of the International Society of Paedriatric Oncology (SIOP) , Dublin, Ireland, pp.237, 2016

ECEVİT, Ç. Et Al. (2016) . "Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients." The 48th Congress of the International Society of Paedriatric Oncology (SIOP) , Dublin, Ireland, p.237.

@conferencepaper{conferencepaper, author={ÇİĞDEM ECEVİT Et Al. }, title={Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients}, congress name={The 48th Congress of the International Society of Paedriatric Oncology (SIOP)}, city={Dublin}, country={Ireland}, year={2016}, pages={237} }